New Zealand markets closed

Athira Pharma, Inc. (ATHA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.3100-0.0100 (-0.30%)
At close: 04:00PM EDT
3.2500 -0.06 (-1.81%)
After hours: 07:02PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
-
Operating expenses
Research development
93,733
93,790
61,464
42,794
13,286
-
Selling general and administrative
31,278
33,304
32,552
21,228
6,709
-
Total operating expenses
125,011
126,937
88,855
55,187
18,674
-
Operating income or loss
-125,011
-126,937
-88,855
-55,187
-18,674
-
Interest expense
-
-
-
3
367
346
Total other income/expenses net
8,822
9,265
-6,784
334
-1,038
-
Income before tax
-116,189
-117,672
-95,639
-54,853
-19,955
-
Income from continuing operations
-116,189
-117,672
-95,639
-54,853
-19,955
-
Net income
-116,189
-117,672
-95,639
-54,853
-19,955
-
Net income available to common shareholders
-116,189
-117,672
-95,639
-55,274
-19,955
-
Basic EPS
-3.17
-
-2.53
-1.49
-1.67
-0.60
Diluted EPS
-3.17
-
-2.53
-1.49
-1.67
-0.60
Basic average shares
37,958
-
37,733
36,921
11,967
8,604
Diluted average shares
37,958
-
37,733
36,921
11,967
8,604